18 Jan What does the future of clinical trials and evidence-based medicine look like?
The pandemic exposed existing clinical trial limitations and improved trial design by increasing focus on the prime subject of research, the patient....
News
17 Jan Opinion: Technology can make clinical trials equitable and accessible
Posted at 16:35h
in Recruitment, Clinical Trials, Health Equity, Clinical Research, Diversity, Technology
Technology that streamlines processes, provides transparency into clinical operations and enables robust data collection will empower sponsors to more rapidly enroll clinical studies and to study medicines in the diverse populations which they will serve. ...
17 Jan Better recognition for research participants: What society should learn from COVID-19
Doing more to acknowledge the important role of clinical trials participants could help with recruitment....
16 Jan The long-term impact of COVID-19 on clinical trials: Part 2
An analysis of the pandemic's impacts on broader organizational and sector level dynamics in clinical research such as competitor collaboration, globalization, industry goodwill, public health, supply chain, and workplace environment....
13 Jan A blood test for cancer shows promise thanks to machine learning
A team of researchers at the University of Wisconsin–Madison has successfully combined genomics with machine learning in the quest to develop accessible tests that allow earlier detection of cancer....
12 Jan Clearing up ‘social determinants of health’
'Social determinants of health' is used often by public health personnel, but for many people, the meaning isn't clear....
12 Jan Association of Clinical Research Professionals’ response to FDA draft guidance on diversity in clinical trials
Increased diversity in clinical trials should be a requirement, not a suggestion....
12 Jan Harnessing data to foster research and improve public health
The COVID-19 pandemic radically changed our perspectives on how to conduct research and clinical care, and it set the stage for data-driven biomedical research and clinical practice....
11 Jan The long-term impact of COVID-19 on clinical trials: Part 1
The pre-pandemic environment for clinical trials has been described as unsustainable by many observers, so the massive disruption caused by COVID-19 also presents ripe opportunities for improvement....
11 Jan FDA approves drug to help with early Alzheimer’s
UW Health's Dr. Nathaniel Chin discusses the impact of lecanemab and the future of Alzheimer's and dementia-related clinical research....